Candriam S.C.A. - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 226 filers reported holding BEAM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,118,443
-24.7%
129,6650.0%0.02%
-26.7%
Q2 2023$4,140,203
+84.4%
129,665
+62.8%
0.03%
+87.5%
Q1 2023$2,245,241
-27.9%
79,6650.0%0.02%
-23.8%
Q4 2022$3,115,552
-17.9%
79,6650.0%0.02%
-22.2%
Q3 2022$3,795,000
+23.1%
79,6650.0%0.03%
+8.0%
Q2 2022$3,084,000
-30.2%
79,665
+3.3%
0.02%
-16.7%
Q1 2022$4,420,000
-28.1%
77,1470.0%0.03%
-23.1%
Q4 2021$6,148,000
-8.4%
77,1470.0%0.04%
-15.2%
Q3 2021$6,712,000
-32.4%
77,1470.0%0.05%
-32.4%
Q2 2021$9,930,00077,1470.07%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$189,105,00091.90%
PATHWAY CAPITAL MANAGEMENT, LP 37,399$2,993,00016.59%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,390$17,960,00010.54%
HSG Holding Ltd 796,089$63,719,0004.73%
DC Investments Management, LLC 21,010$1,682,0004.17%
Monashee Investment Management LLC 268,820$21,516,0003.31%
Redmile Group, LLC 2,532,523$202,703,0002.86%
HAMILTON LANE ADVISORS LLC 98,761$7,905,0002.58%
Alphabet Inc. 640,792$51,289,0002.07%
Casdin Capital, LLC 818,820$65,538,0001.95%
View complete list of BEAM THERAPEUTICS INC shareholders